LERIN leuprorelin (as acetate) 5 mg implant pre-filled syringe

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

leuprorelin acetate, Quantity: 5.25 mg (Equivalent: leuprorelin, Qty 5 mg)

Pieejams no:

Sandoz Pty Ltd

Zāļu forma:

Implant

Kompozīcija:

Excipient Ingredients: polylactic acid

Ievadīšanas:

Subcutaneous

Vienības iepakojumā:

1

Receptes veids:

(S4) Prescription Only Medicine

Ārstēšanas norādes:

Palliative treatment of patients with advanced prostate carcinoma.

Produktu pārskats:

Visual Identification: White to slightly yellow rod with a homogenous surface in a prefilled syringe; Container Type: Syringe; Container Material: PE; Container Life Time: 4 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorizācija statuss:

Registered

Autorizācija datums:

2019-07-31